Overview

Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether afamelanotide and narrow band UVB are effective in the treatment of non-segmental vitiligo (NSV).
Phase:
Phase 2
Details
Lead Sponsor:
Clinuvel Pharmaceuticals Limited
Treatments:
Afamelanotide
alpha-MSH